ANTIVIRAL

Our research group has developed by computer modeling methods potential inhibitors of HIV-1 penetration based on the CD4 receptor and peptidomimetics of monoclonal antibodies with a wide spectrum of neutralizing activity (3074, VRC_01, 10E8, N6).